The proposed study will enroll parent-child pairs and is designed to obtain new knowledge and improve hypospadias care. Parent-child pairs will be randomized into different groups over 36 months and participate for at least 6 months.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Mean primary outcome measure 1 score (to be disclosed after final subject completes T3 data collection)*
Timeframe: Post-clinic visit, 1-30 days after the final clinic visit (T3)
Mean primary outcome measure 2 score among 50% of participants (to be disclosed after final subject completes T3 data collection)**
Timeframe: Clinic visit(s), 3-60 days after enrollment (T2a) and up to 12 months after the first clinic visit (T2b). Note some patients will only have T2a.